![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_Podcast_1080x1080%20%281%29.jpg?VersionId=mu6lFwYQj6ao3yZXhxw3U0VMwVhnU6Tx)
What’s hot at ACC.24?
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24, highlighting their context and relevance for practice.
Trials covered include:
0:42 - IVUS-ACS: Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention in Acute Coronary Syndromes
2:22 - Ultimate DAPT: One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes
4:02 - RELIEVE-HF: A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients With HFrEF and HFpEF
6:52 - ORBITA-COSMIC: Coronary Sinus Reducer for the Treatment of Refractory Angina
8:52 - EMPACT-MI: Empagliflozin After Acute Myocardial Infarction
10:15 - REDUCE-AMI: Long-term Beta-blocker Treatment After Acute Myocardial Infarction and Preserved Left Ventricular Ejection Fraction
12:39 - SMART: Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli
14:44 - DEDICATE-DZHK6: Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients at Low to Intermediate Risk
16:56 - PERFORM-TAVR: Protein and Exercise to Reverse Frailty in Older Men and Women Undergoing Transcatheter Aortic Valve Replacement
18:13 - PREVENT: Preventive PCI or Medical Therapy Alone for Atherosclerotic Coronary Vulnerable Plaques
21:32 - FULL REVASC: Ffr-guidance for complete non-culprit REVASCularization
22:46 - DanGer Shock: Danish-German cardiogenic shock trial
25:18 - TARGET BP I: Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.
![View from the Thoraxcenter: TCT 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18028_TCT_Thorax_WrapUp_1920x1080.jpg?VersionId=WZPyQM5YID8Ja2tTG82JqWVrDY4PW5uI&itok=-bh0NRIv)
Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.
![ESC 23 Late-breaking Science Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-16042_IND_ESC_ThoraxReview_1920x1080.jpg?VersionId=aKMl08SiVOIisOXa0Kp6ppYSg3T1FuLX&itok=FaPhFNbK)
![View from the Thoraxcenter: ESC 23 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-08/DELV-16041_ES23_Thorax_Preview_1920x1080.png?VersionId=vIAYlNblFzty.rxRkj4FYJnXNBwsfViF&itok=7At0VBr2)
![Left Main Percutaneous Coronary Revascularization](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-07/DELV-15836_RC-Podcast_Alasnag_1920x1080.png?VersionId=3k5Ei8Hy3JGXuU01xNK8kY0YGVYZ2V.M&itok=b3BaXXuM)
![Artificial Intelligence in Atrial Fibrillation](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-05/DELV-15190_RC-Podcast_Harmon-Lopez_1920x1080%20%283%29.png?VersionId=MoT_llgyx1x4kNfpAxGS.aF18zOhApgi&itok=FJiRsHiz)
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.